| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Juhyun Song | |
| Choon Sang Bae | |||
| P2860 | cites work | Alzheimer's Disease | Q22248111 |
| Exercise enhances learning and hippocampal neurogenesis in aged mice. | Q24537320 | ||
| Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism | Q26766494 | ||
| Insulin in the brain: there and back again | Q26825385 | ||
| Elevated risk of type 2 diabetes for development of Alzheimer disease: a key role for oxidative stress in brain | Q27003253 | ||
| Aberrant insulin signaling in Alzheimer's disease: current knowledge | Q27024222 | ||
| Brain Regulation of Energy Metabolism | Q28079453 | ||
| Glucagon-like peptide-1 receptor is involved in learning and neuroprotection | Q28202403 | ||
| The Physiology of Glucagon-like Peptide 1 | Q28373115 | ||
| Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry | Q28609278 | ||
| An energy budget for signaling in the grey matter of the brain | Q29616192 | ||
| Biology of incretins: GLP-1 and GIP | Q29617302 | ||
| Neurodevelopmental effects of insulin-like growth factor signaling | Q30451424 | ||
| (13)C-labelled microdialysis studies of cerebral metabolism in TBI patients. | Q30722189 | ||
| Insulin signaling, diabetes mellitus and risk of Alzheimer disease. | Q30984271 | ||
| The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease | Q33600053 | ||
| The role of gastrointestinal hormones in the pathogenesis of obesity and type 2 diabetes | Q33941355 | ||
| Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. | Q33951456 | ||
| Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization | Q34015457 | ||
| Radiation-induced cognitive impairments are associated with changes in indicators of hippocampal neurogenesis | Q34329749 | ||
| Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain | Q34499374 | ||
| Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis | Q34530843 | ||
| Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? | Q34608998 | ||
| Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model | Q34639384 | ||
| Peptide hormone exendin-4 stimulates subventricular zone neurogenesis in the adult rodent brain and induces recovery in an animal model of Parkinson's disease. | Q55044523 | ||
| Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain | Q83396445 | ||
| Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease. | Q34655623 | ||
| Preproglucagon neurons project widely to autonomic control areas in the mouse brain. | Q34981134 | ||
| Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial | Q35679839 | ||
| Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline | Q35858095 | ||
| Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis | Q35960169 | ||
| Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb | Q36038860 | ||
| Adult neurogenesis: from precursors to network and physiology | Q36079007 | ||
| Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells | Q36137689 | ||
| Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders | Q36166654 | ||
| Hormonal regulation of food intake. | Q36267766 | ||
| Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study | Q36310176 | ||
| History of medically treated diabetes and risk of Alzheimer disease in a nationwide case-control study | Q36942194 | ||
| Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function. | Q36979291 | ||
| Incretin-based therapies for type 2 diabetes mellitus | Q37483473 | ||
| Role of the glucagon-like-peptide-1 receptor in the control of energy balance | Q37708356 | ||
| Brain: normal variations and benign findings in fluorodeoxyglucose-PET/computed tomography imaging. | Q37720604 | ||
| Preproglucagon derived peptides GLP-1, GLP-2 and oxyntomodulin in the CNS: role of peripherally secreted and centrally produced peptides | Q37773639 | ||
| Neuroprotective properties of GLP-1: theoretical and practical applications | Q37827497 | ||
| Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects | Q37988231 | ||
| Animal models of Alzheimer disease | Q38045853 | ||
| PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease | Q38087439 | ||
| Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases | Q38133759 | ||
| Impaired insulin signaling and mechanisms of memory loss. | Q38174298 | ||
| Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. | Q38195478 | ||
| Brain network markers of abnormal cerebral glucose metabolism and blood flow in Parkinson's disease | Q38254740 | ||
| WNT signaling: an emerging mediator of cancer cell metabolism? | Q38263093 | ||
| Diabetes and Alzheimer's disease crosstalk | Q38770716 | ||
| Association of low GLP-1 with oxidative stress is related to cardiac disease and outcome in patients with type 2 diabetes mellitus: a pilot study | Q38919256 | ||
| Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease | Q39124093 | ||
| Energy and the Alzheimer brain | Q39133959 | ||
| Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease | Q39984367 | ||
| Insulin in Brain and Other Extrapancreatic Tissues of Vertebrates and Nonvertebrates | Q40169504 | ||
| Metabolic coupling during activation. A cellular view | Q41545771 | ||
| Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's disease | Q43207399 | ||
| Melatonin acts through MT1/MT2 receptors to activate hypothalamic Akt and suppress hepatic gluconeogenesis in rats. | Q43605073 | ||
| Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients | Q43705651 | ||
| Lack of effect of exendin-4 and glucagon-like peptide-1-(7,36)-amide on insulin action in non-diabetic humans | Q44178339 | ||
| A role for adult neurogenesis in spatial long-term memory. | Q45226040 | ||
| Selective insulin resistance in homeostatic and cognitive control brain areas in overweight and obese adults | Q47666782 | ||
| Insulin gene expression and insulin synthesis in mammalian neuronal cells | Q48084097 | ||
| Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus | Q48103424 | ||
| Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain | Q48248819 | ||
| Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease | Q48270990 | ||
| Long-term potentiation enhances neurogenesis in the adult dentate gyrus. | Q48515412 | ||
| The effect of ageing on neurogenesis and oxidative stress in the APP(swe)/PS1(deltaE9) mouse model of Alzheimer's disease | Q48615135 | ||
| Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem | Q48794136 | ||
| The glucagon-like peptide 1 receptor agonist exendin-4 improves reference memory performance and decreases immobility in the forced swim test. | Q50662877 | ||
| Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats. | Q50963300 | ||
| The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. | Q51011184 | ||
| Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation. | Q51484711 | ||
| Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. | Q51550359 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain | Q1073 |
| nervous system | Q9404 | ||
| hormone | Q11364 | ||
| insulin resistance | Q1053470 | ||
| neurogenesis | Q1456827 | ||
| dementia | Q83030 | ||
| complications of diabetes mellitus | Q4198677 | ||
| neuronitis | Q17157137 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P577 | publication date | 2017-11-22 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | The Role of Glucagon-Like Peptide 1 (GLP1) in Type 3 Diabetes: GLP-1 Controls Insulin Resistance, Neuroinflammation and Neurogenesis in the Brain | |
| P478 | volume | 18 |
| Q89977492 | Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan |
| Q58590774 | Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects |
| Q58572799 | Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1 |
| Q64103346 | Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System |
| Q57167142 | Effects of Acupuncture on Alzheimer's Disease: Evidence from Neuroimaging Studies |
| Q92005722 | Effects of glucagon-like peptide 1 receptor agonists on comorbidities in older patients with diabetes mellitus |
| Q90322035 | Neurodegeneration in type 2 diabetes: Alzheimer's as a case study |
| Q99626811 | Neurogenesis After Stroke: A Therapeutic Perspective |
| Q59812434 | Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function |
| Q89594509 | The dipeptidyl peptidase-4 inhibitor, linagliptin, improves cognitive impairment in streptozotocin-induced diabetic mice by inhibiting oxidative stress and microglial activation |
Search more.